APA (7th ed.) Citation

Babyshkina, N. N., Dronova, T. A., Zambalova, E. A., Zavyalova, M. V., Slonimskaya, E. M., & Cherdyntseva, N. V. (2020). The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients. Бюллетень сибирской медицины, 19(1), 13-20. https://doi.org/10.20538/1682-0363-2020-1-13-20

Chicago Style (17th ed.) Citation

Babyshkina, N. N., T. A. Dronova, E. A. Zambalova, M. V. Zavyalova, E. M. Slonimskaya, and N. V. Cherdyntseva. "The Role of Epidermal Growth Factor Receptor (EGFR) in the Efficacy of Neoadjuvant Chemotherapy in Triple-negative Breast Cancer Patients." Бюллетень сибирской медицины 19, no. 1 (2020): 13-20. https://doi.org/10.20538/1682-0363-2020-1-13-20.

MLA (9th ed.) Citation

Babyshkina, N. N., et al. "The Role of Epidermal Growth Factor Receptor (EGFR) in the Efficacy of Neoadjuvant Chemotherapy in Triple-negative Breast Cancer Patients." Бюллетень сибирской медицины, vol. 19, no. 1, 2020, pp. 13-20, https://doi.org/10.20538/1682-0363-2020-1-13-20.